CAS 115956-12-2
:Dolasetron
Beschreibung:
Dolasetron is an antagonist of the serotonin (5-HT) receptor subtype 5-HT
3
(K
i
= 20 nM).
1
It is selective for 5-HT
3
receptors over 5-HT
1A
, 5-HT
1B
, 5-HT
2
, dopamine D
2
, α
1
-, α
2
-, β-adrenergic, M
1-5
muscarinic acetylcholine, and neurokinin-1 (NK
1
) receptors (IC
50
s = >10 μM for all).
2
Dolasetron inhibits 5-HT-induced membrane currents in NG 108-15 cells (IC
50
= 3.8 nM).
1
It increases the latency to emesis and reduces the number of vomiting and retching episodes induced by cisplatin (Item No.
13119
) in ferrets when administered at doses of 0.5 or 2 mg/kg.
2
Formulations containing dolasetron have been used in the prevention of postoperative or chemotherapy-induced nausea.
Formel:C19H20N2O3
InChl:InChI=1/C19H20N2O3/c22-17-10-21-13-5-12(17)6-14(21)8-15(7-13)24-19(23)18-16-4-2-1-3-11(16)9-20-18/h1-4,12-15H,5-10H2
InChI Key:InChIKey=UKTAZPQNNNJVKR-MMUVGSQPNA-N
SMILES:O(C(=O)C=1C=2C(NC1)=CC=CC2)[C@@H]3C[C@]4([N@]5[C@](CC(C4)C(=O)C5)(C3)[H])[H]
Synonyme:- (2alpha,6alpha,8alpha,9abeta)-Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl-1H-indole-3-carboxylate
- (6R)-3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2α,6α,8α,9aβ)-
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, stereoisomer
- 1H-indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
- 2,6-Methano-2H-quinolizine, 1H-indole-3-carboxylic acid deriv.
- 3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-isoindole-3-carboxylate
- Anemet
- Mdl 73147
- Dolasetron
- 1H-Indole-3-carboxylicacid, octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl ester, stereoisoMer
- Dolasteron
- Unii-82wi2L7Q6e
- 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2alpha,6alpha,8alpha,9abeta)-
- Octahydro-3-oxo-2,6-Methano-2H-quinolizin-8-yl Ester
- rel-(5s,6R,8r,9aS)-3-Oxooctahydro-1H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate
- 1H-Indole-3-carboxylic Acid 3-Oxooctahydro-2H-2,6-methanoquinolizin-8-yl Ester
- Hsdb 7565
- dolasetron USP/EP/BP
- Dolasetronum [inn-latin]
- (2a,6a,8a,9ab)-1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
- Dolasetronum
- Weitere Synonyme anzeigen
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
13 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Dolasetron
CAS:Formel:C19H20N2O3Reinheit:>98.0%(HPLC)Farbe und Form:White to Almost white powder to crystalineMolekulargewicht:324.38Dolasetron-d4 (Indole-d4)
CAS:Formel:C19H16D4N2O3Farbe und Form:Off-White SolidMolekulargewicht:328.40Dolasetron
CAS:Kontrolliertes ProduktApplications Bridged pseudopelletierine derivative; specific serotonin (5HT3) receptor antagonist. Antiemetic.
References Boeijinga, P.H., et al.: Eur. J. Pharmacol., 219, 9 (1992), Miller, R.C., et al., Drug Dev. Res., 28, 87 (1993), Fauser, A.A., et al.: Eur. J. Cancer, 32, 1523 (1996), Graczyk, S.G., et al.: Anesth. Analg., 84, 325 (1997),Formel:C19H20N2O3Farbe und Form:NeatMolekulargewicht:324.37Dolasetron
CAS:Dolasetron (MDL-73147)(MDL-73147) is a serotonin 5-HT3 receptor antagonist. Dolasetron is used to treat nausea and vomiting following chemotherapy.Formel:C19H20N2O3Reinheit:99.84% - 99.86%Farbe und Form:SolidMolekulargewicht:324.3737Dolasetron
CAS:rel-(5s,6R,8r,9aS)-3-Oxooctahydro-1H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylateFormel:C19H20N2O3Reinheit:98%Molekulargewicht:324.37Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester
CAS:Dolasetron mesylate is a mesylate of the biologically active form of dolasetron, which is an octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester. Dolasetron has been shown to be effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy or radiation therapy. It has been approved for use in adults with cancer who have not responded to other treatments. Dolasetron is rapidly absorbed from the gastrointestinal tract and is then distributed throughout the body, including into the brain. The elimination half life of dolasetron mesylate is about 2 hours and it binds to plasma proteins. Dolasetron mesylate specifically binds to serotonin receptors, which are found on cells in the gut. This binding inhibits serotonin induced contraction of bowel smooth muscle cells.Formel:C19H20N2O3Reinheit:Min. 95%Farbe und Form:White To Off-White To Grey SolidMolekulargewicht:324.37 g/mol










